QIAGEN powered by
Interested in offering precision oncology testing in your lab?

QIAGEN Digital Insights Wednesday, May 12, 2021

On Thursday, May 20, join us for the Every Lab Summit, a free virtual event exploring how any lab, anywhere,…

Quality over quantity: Why national reference labs trust HGMD Professional

QIAGEN Digital Insights Friday, May 7, 2021

When a family has a child with a rare undiagnosed condition,  a woman is diagnosed with an aggressive form of…

5 reasons why you should use COSMIC to identify cancer mutations

QIAGEN Digital Insights Friday, May 7, 2021

COSMIC, the Catalogue Of Somatic Mutations In Cancer, is the world’s largest and most comprehensive resource for exploring the impact…

COSMIC – Powering Precision Oncology Research and Development

QIAGEN Digital Insights Thursday, April 1, 2021

Around two decades ago, the amount of data about cancer genomes began to increase rapidly. Managing, viewing, and searching for…

Harness the power of deeply-curated scRNA-seq data to accelerate discovery and validation

QIAGEN Digital Insights Tuesday, March 30, 2021

Discover our new platform for exploring highly–curated single-cell RNA-seq data  Are you looking for highly curated single-cell (scRNA-seq) data to…

Announcing the 2021.1 Release of HGMD® Professional

QIAGEN Digital Insights Friday, March 19, 2021

The Spring release of HGMD Professional is now available. Containing over 314,707 expert-curated disease-causing mutations, HGMD remains the largest, most…

Scale up, quickly and easily: SARS-CoV-2 genomic surveillance data analysis

QIAGEN Digital Insights Monday, March 8, 2021

It’s already happened: Several SARS-CoV-2 variants are upon us, lurking in various populations, bringing more uncertainty about how this pandemic…

Building workflows for SARS-CoV-2 mutation analysis in QIAGEN CLC Genomics Workbench

QIAGEN Digital Insights Friday, March 5, 2021

During the current pandemic, the importance of continually monitoring viral genomes for new mutations has become fundamental to help guide…

Using the Interactive Filter Cascade in QCI Interpret Translational

QIAGEN Digital Insights Wednesday, February 17, 2021

Whole-exome sequencing (WES) using next-generation sequencing (NGS) technology is a powerful tool for investigating variants linked to genetic disease. It…

Overcoming Challenges in Variant Filtering and Prioritization

QIAGEN Digital Insights Wednesday, February 17, 2021

Next-generation sequencing (NGS) techniques allow high-throughput detection of a vast amount of genetic variations in a cost-effective manner. However, there…

The key to target and biomarker discovery

QIAGEN Digital Insights Tuesday, February 16, 2021

Hint: The secret is in the biological context Today’s discovery scientists are challenged with identifying new biomarkers and therapeutic targets…

QIAGEN Digital Insights Publication Roundup (Spring 2021)

QIAGEN Digital Insights Monday, February 8, 2021

Read about how researchers across the world are using QIAGEN Digital Insights solutions to accelerate their work in a variety…